Histamine H3 receptor (antagonist / inverse agonist) drugs for Narcolepsy
2 tracked Histamine H3 receptor (antagonist / inverse agonist) drugs in the Narcolepsy race. The class explanation lives on the Histamine H3 receptor (antagonist / inverse agonist) page; the full indication pipeline across every mechanism is on the Narcolepsy page.
1 approved / phase 41 preclinical / unstaged
Head-to-head evidence: Pitolisant GR vs Pitolisant (Wakix)
The roster
← all Histamine H3 receptor (antagonist / inverse agonist) drugs